The person who uses clinical AI is not always the person who can fund it. A doctor may value a tool, a library may assess its evidence access, an education team may need learning outcomes and a clinical service may require workflow assurance. A credible purchasing proposal identifies each role rather than treating enthusiasm as a funded route to adoption.
Follow one product through three conversations
Consider a hypothetical platform that provides referenced answers and educational practice. The following purchasing scenarios are original illustrations, not descriptions of any institution's actual budget or procurement rules.
A medical librarian asks whether it adds something beyond existing subscriptions and whether use can be reported meaningfully. An education lead asks how it fits a programme and what learners can do that they could not do before. A clinical service lead asks whether the intended use affects patient care, staff work or organisational risk.
The product may be the same, but the decision is not. A single slide about "saving clinicians time" is unlikely to answer all three questions adequately.
The library conversation: access, evidence and accountability
A library may need to understand content coverage, access conditions, source transparency and the relationship with existing resources. The proposal should identify whether the tool replaces a purchase, supplements it or creates a new kind of access.
Do not assume that an answer without a click means the underlying content was unused. Conversely, do not count every retrieved passage as equivalent to a reader engaging with an article. These distinctions are part of the emerging discussion about AI-mediated usage reporting.
COUNTER's update of 18 September 2026 discusses developing guidance for generative and agentic AI, with a further phase planned for October. It does not establish that every supplier already provides standardised AI reports.
For the hypothetical library buyer, a practical pilot would therefore define which usage and source-access questions it is trying to answer before asking for a dashboard.
The education conversation: a place in the programme
An education lead needs a defined learning activity. "Students can ask anything" may be useful, but it is not a complete implementation plan.
Specify whether the tool supports independent revision, consultation rehearsal, formative discussion or another task. Identify what faculty must prepare, how learners receive support and whether the product supplies the required functionality or merely suggests an attractive possibility.
Do not promise institutional assignment tools, faculty dashboards or assessment integration unless they are actually available and documented. A product can be valuable for individual use without already being an institution-wide learning-management system.
The pilot should also distinguish engagement from learning. Completion and satisfaction can establish whether an activity is usable; they do not alone demonstrate retained knowledge or better clinical performance.
The clinical-service conversation: intended use and responsibility
A service considering clinical use needs a different discussion from a department purchasing examination practice. Map the function, inputs, outputs and review responsibilities. Establish what happens when information is missing or the system produces an unsuitable result.
The MHRA's software guidance, checked on 19 September 2026, is a relevant UK reference for examining software functions and medical-device questions. It should not be reduced to a badge that answers every deployment issue.
A learning subscription does not become a clinical deployment approval because clinicians already like it. Equally, the organisation's purchase of a clinical tool does not establish that every educational feature meets its teaching needs.
Keep the proposed task narrow enough that responsibilities can be described. A promise to "support all clinical work" makes both evaluation and ownership harder.
Map four roles before discussing price
For each opportunity, record the user, budget holder, approver and beneficiary. A single person may occupy more than one role, but the roles should not disappear from the analysis.
The user experiences the workflow. The budget holder decides whether money is available for the proposed purpose. Approvers assess the relevant clinical, technical, legal or organisational requirements. The beneficiary receives the intended improvement, which may be the user, the organisation, patients or learners.
Then ask what evidence each role needs. A clinician's positive feedback may support usability while leaving the budget case unanswered. A budget allocation may support purchase while leaving deployment approval unresolved.
This role map is an original commercial framework, not a statement that all organisations use identical approval structures.
Price the implementation, not only the licence
A proposal should identify the subscription or contract price alongside preparation, onboarding, support, integration and review work where relevant. A low licence price can still require substantial staff time; a broader package may include services that should not be compared with a bare individual subscription.
For a pilot, specify what happens when introductory access ends. Who reviews the evidence, when is the renewal decision made and what budget would support continuation? Without that route, a successful trial can end because nobody owns the next decision.
Avoid treating free access as free implementation. Users still need an appropriate task, usable onboarding and clarity about the limits of the service.
Where iatroX fits, and where assumptions must stop
This article is published by iatroX and includes its own offerings. As described on 19 September 2026, iatroX Insights provides clinical-safety, digital-health advisory, research and partnership services. The individual learning platform has a separate subscription proposition.
That creates different possible conversations, not proof that a single budget can fund everything. A clinician buying personal revision may need no institutional programme. A university exploring learning use would need to establish the actual supported workflow. A service seeking advisory work would need a defined scope and deliverables.
For each buyer, the question is the same: what exactly is being purchased, for whom, through which approval route and with what evidence of value? Clear answers are more useful than presenting every interested clinician as a future enterprise sale.
Frequently asked questions
Does clinician demand prove that an organisation has a budget for the tool?
No: demand identifies a possible need, not a funded purchasing route. Establish the budget holder, intended use and approval process.
Should library and education purchases use the same success measures?
Some measures may overlap, but the principal tasks differ. Source access, learning outcomes and clinical workflow effects should be assessed against the relevant purchase.
Is a free pilot enough to establish institutional readiness?
No: define implementation responsibilities, evidence requirements and the route to a funded continuation. A usable pilot can still lack an owner for renewal.
Discuss the appropriate organisational use case with iatroX Insights →